Plain-English translation of NCT07267130 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This early-stage trial is testing a new inhaled medication called TQC3302 to see if it is safe and how your body processes it. The study will give healthy adults different doses of TQC3302 and sometimes compare it to other existing inhaled medications used for lung disease. Researchers want to understand whether this medication could eventually help patients with chronic obstructive pulmonary disease (a long-term lung condition).
Before any new medication can be tested in people who are sick, it must first be carefully tested in healthy volunteers to make sure it is safe and to understand how the body absorbs and uses it. This trial is an important first step to gather that information.
You likely qualify if…
You likely don't qualify if…
You will visit the research site multiple times over several weeks. At each visit, you'll inhale the medication through a special spray device, and researchers will monitor you for any side effects. You'll also have blood tests and breathing tests done to measure how your body responds to and processes the medication. Most visits last a few hours, and the entire study takes about 4–6 weeks depending on which group you're in.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China